Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medbright AI Investments Inc MBAIF


Primary Symbol: C.MBAI

MedBright AI Investments Inc. is a capital allocator focused on investing in healthcare technology companies. The Company is engaged in constructing a portfolio of synergistic investments to generate returns for shareholders. The Company is focused on significant near-term and midterm opportunities with potential returns while maintaining a commitment to governance. It is focused on investing in technology and artificial intelligence companies, combined with healthcare operators.


CSE:MBAI - Post by User

Post by 1StockInformeron Mar 21, 2024 7:26pm
47 Views
Post# 35946071

MBAI Enhances Healthcare Operations Through Innovative...

MBAI Enhances Healthcare Operations Through Innovative...

In the realm of healthcare management, technological advancements play a pivotal role in streamlining operations and improving patient care. One such advancement comes from MedBright AI Investments Inc. (CSE:MBAI, OTCQB:MBAIF), a company dedicated to investing in cutting-edge healthcare technology solutions. 


MBAI recently announced another strategic deal with Rejuvenation Medical Group, a prominent healthcare provider in Canada, aimed at revolutionizing clinic operations through the adoption of advanced AI technology.


At the core of this partnership lies MBAI's MedMatrix AI Platform and its AI Reporter feature. This software offers comprehensive data reporting and forecasting capabilities, providing clinics like Rejuvenation Medical Group with valuable insights into their operations. 


By leveraging MedMatrix AI Reporter, Rejuvenation gains the ability to centralize reporting processes across its network of eight clinics spread across three provinces in Canada.


Through the integration of this innovative technology, Rejuvenation aims to optimize resource utilization, expand clinic accessibility, and boost revenue generation. 


Dr. Paul Kuzel, Medical Director and Dermatologist at Rejuvenation Medical Group, expressed enthusiasm for the potential of MedMatrix AI Reporter, highlighting its ability to identify opportunities for improvement within the clinic.


Beyond its immediate benefits to Rejuvenation Medical Group, this partnership serves as a testament to MBAI's expertise in healthcare technology investment. By providing Rejuvenation with tailored AI solutions, MBAI demonstrates its commitment to driving tangible results for its clients. 


Looking ahead, MBAI remains dedicated to fostering strategic partnerships that drive innovation and improve healthcare management practices. 


Through its portfolio of synergistic investments, MBAI continues to position itself as a trusted partner for healthcare providers seeking to leverage the power of AI technology.


Full news here: https://financialpost.com/globe-newswire/rejuvenation-medical-group-of-canada-uses-medmatrix-ai-reporter-to-streamline-reporting-and-improve-operations
 

Posted on behalf of MedBright AI Investments Inc.

 
<< Previous
Bullboard Posts
Next >>